Testing effectiveness (Phase 2)Study completedNCT01895036
What this trial is testing
Nalrexone Facilitated Discontinuation of Buprenorphine
Who this might be right for
Stable Opioid Dependence
New York State Psychiatric Institute 6
Showing 10 of 10 results